Dr. Jan Rosenbaum, PhD, Scientific Advisory Board
Jan has more than 30 years of pharma/biotech technical management experience in innovation and in leading early-stage drug discovery projects. She is currently Kurome Therapeutics’ President, CEO, and CSO. Prior to that, she was a group leader at Procter & Gamble Pharmaceuticals, and then the chief scientific officer of Airway Therapeutics, a startup company of the CincyTech portfolio. In addition, she served as a business development advisor on the Therapeutics Development Team of the Harrington Discovery Institute, University Hospitals, Cleveland, OH, and chairs the Science & Industry Advisory Committee for IRICoR, University of Montréal, Canada. She is an inventor on 20 patents and is an author more than 35 publications. Jan brings her startup drug discovery expertise and management skills to Mogling Bio.